HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phytocannabinoids and epilepsy.

AbstractWHAT IS KNOWN AND OBJECTIVE:
Antiepileptic drugs often produce serious adverse effects, and many patients do not respond to them properly. Phytocannabinoids produce anticonvulsant effects in preclinical and preliminary human studies, and appear to produce fewer adverse effects than available antiepileptic drugs. The present review summarizes studies on the anticonvulsant properties of phytocannabinoids.
METHODS:
Literature search using the PubMed database to identify studies on phytocannabinoids and epilepsy.
RESULTS AND DISCUSSION:
Preclinical studies suggest that phytocannabinoids, especially cannabidiol and cannabidivarin, have potent anticonvulsant effects which are mediated by the endocannabinoid system. Human studies are limited in number and quality, but suggest that cannabidiol has anticonvulsant effects in adult and infantile epilepsy and is well tolerated after prolonged administration.
WHAT IS NEW AND CONCLUSION:
Phytocannabinoids produce anticonvulsant effects through the endocannabinoid system, with few adverse effects. Cannabidiol and cannabidivarin should be tested in randomized, controlled clinical trials, especially in infantile epileptic syndromes.
AuthorsR G dos Santos, J E C Hallak, J P Leite, A W Zuardi, J A S Crippa
JournalJournal of clinical pharmacy and therapeutics (J Clin Pharm Ther) Vol. 40 Issue 2 Pg. 135-43 (Apr 2015) ISSN: 1365-2710 [Electronic] England
PMID25475762 (Publication Type: Journal Article, Review)
Copyright© 2014 John Wiley & Sons Ltd.
Chemical References
  • Anticonvulsants
  • Cannabinoids
  • Endocannabinoids
  • Plant Extracts
  • Cannabidiol
  • Dronabinol
  • cannabidivarin
Topics
  • Animals
  • Anticonvulsants (therapeutic use)
  • Cannabidiol (therapeutic use)
  • Cannabinoids (therapeutic use)
  • Cerebral Cortex (metabolism)
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Dronabinol (therapeutic use)
  • Drug Evaluation, Preclinical
  • Endocannabinoids (biosynthesis)
  • Epilepsy (drug therapy)
  • Humans
  • Phytotherapy
  • Plant Extracts (chemistry, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: